Zum Inhalt

Heath State Utility Values for Cost-Effectiveness Models

  • 01.12.2017
  • Editorial
Erschienen in:

Auszug

Most contemporary clinical trials of new technologies collect health-related quality of life (HRQoL) data that can be used to generate utility values. Such data can be used to estimate differences in quality-adjusted life-year (QALY) gains in economic evaluations alongside clinical trials. However, such evaluations rarely represent all important differences in costs and outcomes, and cost-effectiveness models are commonly used to extrapolate beyond a trial’s time horizon to estimate longer-term costs and QALY gains [1]. …
Titel
Heath State Utility Values for Cost-Effectiveness Models
Verfasst von
Jonathan Karnon
Publikationsdatum
01.12.2017
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe Sonderheft 1/2017
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-017-0537-x
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.